Shopping Cart (0)
My Account

Your Shopping Cart
ISEV2014 Educational EventBiofluid Biopsies and Companion Diagnostics 2014Clinical Applications of Mass SpectrometryFood Analysis CongressAdvances in Stem Cell Research 2014 - Online Event20% Discount OfferePoster Award PrizeBlogs

Epigenetics Market Trends 2011

Publisher: Select Biosciences
Published: January 2011
Pages: 76

Price:



This is the latest and most up-to-date Market Report from Select Biosciences addressing the expanding epigenetics marketplace. Epigenetics research efforts are growing around the world driven by the numerous documented associations of epigenetic modifications with diseases—especially various types of cancers.

This report presents the biological role of various epigenetic modifications in vivo and frames them in the context of specific biological events such as differentiation and disease.

This report also examines qualitative and in quantitative terms the research market landscape of epigenetics as it exists currently based on Select Biosciences bottom-up market research on this topic. Presented is market segmentation of epigenetics based on end-user research, based on technology utilization, and based on specific disease areas being studied. The primary market data are derived from a worldwide respondent pool that is highly-representative of the life science research community and therefore provides an excellent proxy for the understanding of the research trends operative in this space.

In addition to characterization of the epigenetics research marketplace, this report also presents an analysis of epigenetic biomarkers and their deployment as potential diagnostics. Also presented herein are the efforts vis-à-vis deployment of epigenetics as therapeutics—in this vein the clinical pipeline as it exists currently is presented.

This data-driven characterization of the epigenetics research landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans.

Extensive Worldwide Technical and Market Analyses Presented in this Report:

  • Characterization of Epigenetics Modifications
  • DNA Methylation, the Various Histone Modifications and their Qualitative Effects In Vivo
  • Epigenetic Silencing of Genes and Pathways: Mechanism and Effects
  • Tumor Suppressor Genes Silenced In Vivo
  • Specific Genes Modulated via Epigenetics In Various Diseases
  • Market Segmentation of Epigenetics by Disease Class
  • Epigenetics Market Segmentation
  • Epigenetics Market Segmentation by End-User Research Penetrance
  • Epigenetics Market Quantitative Segmentation by type of Modification Studied
  • Epigenetics Market Segmentation by Type of HDAC Studied
  • Penetrance of Product Vendors into Various Segments of the Epigenetics Marketplace: Quantitative Analysis
  • Emerging Trends and Themes in Epigenetics
  • Current Studies of microRNAs, non-coding RNAs, and Tumor Suppressor Genes in the Epigenetics Marketplace
  • Epigenetics-based Diagnostics: Epigenetics-based Biomarkers and their Current Status
  • Epigenetics-based Therapeutics: The current Clinical Pipeline of Approved and In-Development Therapeutics
  • More details of the scope of coverage of this industry report are found in the Table of Contents (TOC) for the report—see below for link to downloadable PDF of the TOC

Report Table of Contents (TOC) [Click Here to Download PDF File]


For enquiries about this market report, please contact Kathy Gray at Kathy.Gray@Selectbiosciences.com

Conference News
Call for papers - Advances in qPCR and dPCR 2015, Singapore
Call for papers - Advances in qPCR and dPCR 2015, Singapore
We are now accepting papers for the Advances in qPCR and dPCR meeting which will take place on the 21-22 May 2015 in Singapore.


LAB-ON-A-CHIP ASIA - EARLY BIRD
LAB-ON-A-CHIP ASIA - EARLY BIRD
SAVE UP TO S$150 - EARLY BIRD DEADLINE 10 OCTOBER 2014. Don't miss out - register today!


Keynote Speaker Confirmed, Stephen Minger
We are thrilled to announce that Stephen Minger, Global Director of GE Healthcare, has confirmed he will be giving a keynote presentation at Stem Cells in Drug Discovery 2015.


Challenges and Advances in Targeted and Non-Targeted Analysis of Chemical Contaminants and Adulterants
This workshop will discuss various challenges in the analysis of chemical contaminants and adulterants in food and food supplements and demonstrate on real-life examples how advanced analytical methods can address them.


Papers Presented in the Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference can be Published in CSBJ
Papers Presented in the Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference can be Published in CSBJ
Computational and Structural Biotechnology Journal [CSBJ (ISSN 2001-0370)] will devote a conference special issue comprising of selected articles from the speakers/oral and poster presenters of Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference. Selected authors will receive an invitation to submit full length manuscripts to CSBJ. The full length manuscripts will undergo the peer-review process as per CSBJ policies. From July-2014, CSBJ will be part of ELSEVIER Open-access


Keynote Speakers Confirmed, Carlos Caldas and Mark Caulfield
We are thrilled to announce that Professor Carlos Caldas, Group Leader at the Cancer Research UK Cambridge Institute and Professor Mark Caufield, Chief Scientist of the Genomics England 100,000 project, have both confirmed their keynote presentations at Personalized Medicine in May 2015, Cambridge.

Scroll Up
Scroll Down
Keep me updated Select Bio Blog LinkedIn Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com